About the Course/Target Audience

This national symposium will focus on providing an in-depth and up-to-date review of the multidisciplinary management of colorectal cancers.

By Participating, You Will Be Able To:

As a result of attending the course, the participant will be able to:

• Evaluate genomics-based treatment decision-making in colorectal cancer therapy.
• Evaluate total neoadjuvant therapy approaches to rectal cancer.
• Identify personalized approaches to metastatic colorectal cancer.

Who Should Attend?

Oncologists, radiation oncologists, surgeons, and nurses with an interest in the management of patients with colorectal cancer should attend this course